Recruiting
Phase 3

POWER II

Sponsor:

University of Virginia

Code:

NCT06507618

Conditions

Breast Cancer Female

Eligibility Criteria

Sex: Female

Age: 65+

Healthy Volunteers: Not accepted

Interventions

Tamoxifen, Letrozole, Anastrozole, or Exemestane

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-08. This information was provided to ClinicalTrials.gov by University of Virginia on 2025-09-16.